Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03KLN
|
||||
Former ID |
DNC005727
|
||||
Drug Name |
1-(3-Methoxy-naphthalen-2-yl)-1H-imidazole
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527801] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H12N2O
|
||||
Canonical SMILES |
COC1=CC2=CC=CC=C2C=C1N3C=CN=C3
|
||||
InChI |
1S/C14H12N2O/c1-17-14-9-12-5-3-2-4-11(12)8-13(14)16-7-6-15-10-16/h2-10H,1H3
|
||||
InChIKey |
HDJQGQGNKJFUSV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 19 | Target Info | Inhibitor | [527801] | |
Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [527801] | ||
NetPath Pathway | FSH Signaling Pathway | ||||
PANTHER Pathway | Androgen/estrogene/progesterone biosynthesis | ||||
PathWhiz Pathway | Androgen and Estrogen MetabolismPW000141:Steroidogenesis | ||||
WikiPathways | Metapathway biotransformation | ||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Ovarian Infertility Genes | |||||
Metabolism of steroid hormones and vitamin D | |||||
FSH signaling pathway | |||||
Integrated Breast Cancer Pathway | |||||
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation | |||||
Corticotropin-releasing hormone | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.